Skip to main content
Clinical Trials/ISRCTN48327946
ISRCTN48327946
Completed
N/A

Gait analysis of changes in clinical and biomechanical parameters in osteoarthritis knee patients after intra-articular infiltration with high molecular weight hyaluronic acid (Hyalubrix®): a randomised intra-patient comparison clinical study

Fidia Farmaceutici S.p.A. (Italy)0 sites30 target enrollmentJuly 21, 2009

Overview

Phase
N/A
Intervention
Not specified
Conditions
Knee osteoarthritis
Sponsor
Fidia Farmaceutici S.p.A. (Italy)
Enrollment
30
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 21, 2009
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Fidia Farmaceutici S.p.A. (Italy)

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged at least 40 years old, either sex
  • 2\. Presence of grade 2 or 3 (according to the Kellegren and Lawrence scale) osteoarthritis (OA) of one knee
  • 3\. Knee with pain greater than 4 on the Numerical Rating Scale (NRS)

Exclusion Criteria

  • 1\. Concurrent presence of pathologies such as rheumatoid arthritis, gout, hip arthritis
  • 2\. Presence of skin infections near the knee
  • 3\. Use of corticosteroid in the last 3 months
  • 4\. Simultaneous anticoagulant therapy
  • 5\. Use of joint protective drugs
  • 6\. Clotting anomalies
  • 7\. Knee valgus
  • 8\. Known adverse reactions to hyaluronic acid
  • 9\. Presence of knee replacement or impending knee replacement surgery

Outcomes

Primary Outcomes

Not specified

Similar Trials